Dr. Sarah Debussche
The computed 12-month bankruptcy probability of Dr. Sarah Debussche is 2.2% (moderate). The 2025 annual accounts show equity of €273k and a net result of €124k. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €273k |
| Net result | €124k |
| Active | 2 yrs |
| Locations | 1 |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Fiscal year | 2025 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €170k |
| Net profit | €124k |
| Cash flow | €134k |
| Staff costs | - |
| Income taxes | €36k |
| Dividends | - |
| Total assets | €319k |
| Equity | €273k |
| Debt | €46k |
| of which ≤ 1y | €46k |
| of which > 1y | - |
| Working capital | €232k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 6.05 |
| Quick ratio | 6.05 |
| Working capital ratio | 72.7% |
| Solvency | 85.6% |
| Debt / equity | 0.17 |
| Long-term debt ratio | - |
| Interest coverage | 8481.53 |
| Gross margin | - |
| Net margin | - |
| ROA | 38.8% |
| ROE | 45.3% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €319k |
| Fixed assets | 21/28 | €41k |
| Intangible fixed assets | 21 | €2k |
| Tangible fixed assets | 22/27 | €39k |
| Current assets | 29/58 | €278k |
| Investments | 50/53 | €21k |
| Cash & bank | 54/58 | €255k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €319k |
| Equity | 10/15 | €273k |
| Contributions / capital | 10/11 | €1k |
| Reserves | 13 | €272k |
| Amounts payable | 17/49 | €46k |
| Amounts payable within one year | 42/48 | €46k |
| Trade debts payable within one year | 44 | €73 |
| Income statement | ||
| Gross operating margin | 9900 | €170k |
| Operating result | 9901 | €159k |
| Financial income | 75 | €43 |
| Financial charges | 65 | €20 |
| Result before taxes | 9903 | €159k |
| Income taxes | 67/77 | €36k |
| Net result for the period | 9904 | €124k |
| Result to be appropriated | 9905 | €124k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 12-02-2024 |
| Status | Active |
| Postal code | 9070 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44333G0416/00L000 | Flanders | 1,446 m² | 1 · 117 m² | 10.0 m · 2 fl. |
| 44333G0426/00B000 | Flanders | 1,310 m² | 1 · 144 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
| Legal nameNL | Dr. Sarah Debussche |